Case Reports
doi: 10.2340/00015555-1267.
Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone
Affiliations
- PMID: 22113308
- DOI: 10.2340/00015555-1267
Item in Clipboard
Case Reports
Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone
Acta Derm Venereol.
2012 Jul.
Free article
No abstract available
Similar articles
-
Orofacial granulomatosis in children: think about Crohn's disease.Dig Liver Dis. 2015 Apr;47(4):338-41. doi: 10.1016/j.dld.2014.12.012. Epub 2014 Dec 30. Dig Liver Dis. 2015. PMID: 25618553
-
Orofacial granulomatosis: 2 case reports and literature review.J Can Dent Assoc. 2006 May;72(4):325-9. J Can Dent Assoc. 2006. PMID: 16684476 Review.
-
Infliximab: a novel treatment option for refractory orofacial granulomatosis.Acta Derm Venereol. 2007;87(3):265-6. doi: 10.2340/00015555-0219. Acta Derm Venereol. 2007. PMID: 17533496 No abstract available.
-
[Treatment of Crohn's disease by infliximab. About 20 cases].Tunis Med. 2009 Sep;87(9):579-82. Tunis Med. 2009. PMID: 20180377 French.
-
Orofacial granulomatosis--a 20-year review.Oral Dis. 2009 Jan;15(1):46-51. doi: 10.1111/j.1601-0825.2008.01500.x. Oral Dis. 2009. PMID: 19076470 Review.
Cited by
-
Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review.Therap Adv Gastroenterol. 2020 Jul 27;13:1756284820934327. doi: 10.1177/1756284820934327. eCollection 2020. Therap Adv Gastroenterol. 2020. PMID: 32782477 Free PMC article.
-
Orofacial Granulomatosis in Children can be the Initial Manifestation of Systemic Disease: A Presentation of Two Cases.Dermatol Reports. 2014 May 12;6(1):5039. doi: 10.4081/dr.2014.5039. eCollection 2014 Feb 17. Dermatol Reports. 2014. PMID: 25386323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
